Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients

Chinese Medical Journal

Volumn 121, Issue 14, 2008, Pages 1280-1284

  Wang, Shi Xiang ^a   Li, Han ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Bone mass density; Dialysis; Oestoporosis; Salmon calcitonin

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; SALCATONIN;

ABSENCE OF SIDE EFFECTS; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CHRONIC GLOMERULONEPHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DRUG DOSE COMPARISON; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; FEMUR NECK; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY POLYCYSTIC DISEASE; LUMBAR SPINE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 51349091889     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200807020-00007     Document Type: Article

References (20)

1. Silver J, Kilav R, Naveh-Many T. Mechanisms of secondary hyperparathyroidism. Am J Physiol Renal Physiol 2002; 283: F367-F376.
2. Bai RJ, Cong DG, Shen BZ, Han MJ, Wu ZH. Bone diseases in rabbits with hyperparathyroidism: computed tomography, magnetic resonance imaging and histopathology. Chin Med J 2006; 119: 1248-1255.
3. Yin XX, Chen ZQ, Liu ZJ, Ma QJ, Dang GT. Icariine stimulates proliferation and differentiation of human osteoblasts by increasing production of bone morphogenetic protein 2. Chin Med J 2007; 120: 204-210.
4. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. The burden of kidney disease: Improving global outcomes. Kidney Int 2004; 66: 1310-1314.
5. Greenberg JA, Roth EJ, Wuermser LA, Almagor O, Schnitzer TJ. Osteoporosis treatment for patients with stroke. Top Stroke Rehabil 2007; 14: 62-67.
6. Ensrud KE, Fullman RL, Barrett-Connor E, Cauley JA, Stefanick ML, Fink HA, et al. Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab 2005; 90: 1998-2004.
7. Muraki S, Yamamoto S, Ishibashi H, Horiuchi T, Hosoi T, Orimo H, et al. Impact of degenerative spinal diseases on bone mineral density of the lumbar spine in the elderly women. Osteoporos Int 2004; 15: 724-728.
8. Guven Z, Karadag-Saygi E, Unlu-Ozkan F, Akyuz G. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men. Aging Male 2007; 10: 197-201.
9. Dai Y, Shen L. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women. Chin Med J 2007; 120: 2017-2021.
10. Doggrell SA. Present and future pharmacotherapy for osteoporosis. Drugs Today (Barc) 2003; 39: 633-657.
11. Papadokostakis G, Damilakis J, Mantzouranis E, Katonis P, Hadjipavlou A. The effectiveness of calcitonin on chronic back pain and daily activities in postmenopausal women with osteoporosis. Eur Spine J 2006; 15: 356-362.
12. Vistoropsky Y, Keter M, Malkin I, Trofimov S, Kobyliansky E, Livshits G. Contribution of the putative genetic factors and ANKH gene polymorphisms to variation of circulating calciotropic molecules, PTH and BGP. Hum Mol Genet 2007; 16: 1233-1240.
13. Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007; 40: 1434-1446.
14. Sit D, Kadiroglu AK, Kayabasi H, Atay AE, Yilmaz Z, Yilmaz ME. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients. Adv Ther 2007; 24: 987-995.
15. Miller PD. Is there a role for bisphosphonates in chronic kidney disease? Semin Dial 2007; 20: 186-190.
16. Aucella F, Morrone L, Stallone C, Gesualdo L. The genetic background of uremic secondary hyperparathyroidism. J Nephrol 2005; 18: 537-547.
17. Locatelli F, Cannata-Andía JB, Drüeke TB, Hörl WH, Fouque D, Heimburger O, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant 2002; 17: 723-731.
18. Penalba A, Neme G, Tirado S. Vascular and tissue calcifications of hemodialysis patients. Nefrologia 2003; 23 Suppl 2: 112-116.
19. Chung SY, Chen TH, Lai SL, Huang CH, Chen WH. Hypercalcemia and status epilepticus relates to salmon calcitonin administration in breast cancer. Breast 2005; 14: 399-402.
20. Nieves JW, Komar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr 1998; 67: 18-23.